Aclaris Therapeutics (ACRS) Short-term Investments (2014 - 2026)
Aclaris Therapeutics (ACRS) reported Short-term Investments of $72.39 million for Q2 2026, down 2.7% from $74.4 million a year earlier and down 5.7% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Short-term Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics posted Short-term Investments of $70.79 million, down 20.5% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
- By year, Short-term Investments came in at $89.02 million in FY2024 (+12.4%), $79.23 million in FY2023 (-54.0%), $172.29 million in FY2022 (+5.0%) and $164.07 million in FY2021 (+411.6%).
- Five-year quarterly Short-term Investments spans a low of $64.01 million in Q3 2023 and a high of $186.41 million in Q3 2022.
- Year over year, Short-term Investments gained in three of the last eight quarters, with an average decline of 3.7%.
- The high point for year-over-year Short-term Investments in five years was Q4 2021 (growth of 411.6%); the low point was Q3 2023 (a decline of 65.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $76.76 million (Q1 2026), $70.79 million (Q4 2025) and $70.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn |
| 10 | Aclaris Therapeutics | 545.97 Mn | 162.33 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.39 Mn |
| Mar 31, 2026 | 76.76 Mn |
| Dec 31, 2025 | 70.79 Mn |
| Sep 30, 2025 | 70.66 Mn |
| Jun 30, 2025 | 74.40 Mn |
| Mar 31, 2025 | 74.96 Mn |
| Dec 31, 2024 | 89.02 Mn |
| Sep 30, 2024 | 80.07 Mn |
| Jun 30, 2024 | 88.26 Mn |
| Mar 31, 2024 | 92.33 Mn |
| Dec 31, 2023 | 79.23 Mn |
| Sep 30, 2023 | 64.01 Mn |
| Jun 30, 2023 | 88.63 Mn |
| Mar 31, 2023 | 126.08 Mn |
| Dec 31, 2022 | 172.29 Mn |
| Sep 30, 2022 | 186.41 Mn |
| Jun 30, 2022 | 180.34 Mn |
| Mar 31, 2022 | 143.28 Mn |
| Dec 31, 2021 | 164.07 Mn |
| Sep 30, 2021 | 144.28 Mn |
API Access
Aclaris Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();